Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Vasoconstrictors and Hemodynamic Parameters
NCT02285634Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, double-blind trial of Mucinex Full Force Nasal Spray, phenylephrine, lidocaine 10% oropharyngeal spray and epinephrine nasal spray in epistaxis, sponsored by Mayo Clinic. Started Nov 2014; status: completed.
02
Drugs
Mucinex Full Force Nasal Sprayphenylephrinelidocaine 10% oropharyngeal sprayepinephrine nasal spray
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT02285634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285634.